Stock listing

Starpharma Holdings Limited

Selected listing: SPL · ASX · AUD · AU

Starpharma Holdings Limited (ASX:SPL), Health Technology. Latest release Sep 4, 2026: S&P DJI Announces September 2026 Quarterly Rebalance.

SPL:ASXAUDAUUpdated October 2, 2026

Ticker: ASX:SPL
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: ASX
Currency: AUD

About Starpharma Holdings Limited

Starpharma Holdings Limited, trading under the ticker SPL, is a public company listed on the Australian market. Starpharma focuses on developing innovative drug delivery systems and antiviral products.

Latest news from Starpharma Holdings Limited

S&P DJI Announces September 2026 Quarterly Rebalance

September 4, 2026

FY26 Key Financial Results and Annual Report

August 25, 2026

Successful Completion of $32 million Entitlement Offer

August 10, 2026

Entitlement Offer Investor Presentation

July 14, 2026

DEP milestone triggers partner option fee

July 2, 2026

All Starpharma Holdings Limited news →

Research Starpharma Holdings Limited

Starpharma Holdings Limited company profile

View the public company page for Starpharma Holdings Limited on 6ix.

Starpharma Holdings Limited news

Read company news and market updates connected to Starpharma Holdings Limited.

Starpharma Holdings Limited investor events

Find investor webinars, events, and replay context for Starpharma Holdings Limited.